159 related articles for article (PubMed ID: 10234737)
1. Synthesis of some 4-[3' or 4'-(4H- 4-oxo-1-benzopyran-2-yl)phenyl]-1,4-dihydropyridine derivatives as potential calcium channel antagonists.
Tunçbilek M; Ertan R
Pharmazie; 1999 Apr; 54(4):255-9. PubMed ID: 10234737
[TBL] [Abstract][Full Text] [Related]
2. 1,4-Dihydropyridine derivatives as calcium channel modulators: the role of 3-methoxy-flavone moiety.
Budriesi R; Bisi A; Ioan P; Rampa A; Gobbi S; Belluti F; Piazzi L; Valenti P; Chiarini A
Bioorg Med Chem; 2005 May; 13(10):3423-30. PubMed ID: 15848754
[TBL] [Abstract][Full Text] [Related]
3. [Molecular tools for the study of calcium channels: synthesis and evaluation of biological activity of new derivatives of 4-aryl-1,4-dihydropyridine groups].
Soldatov NM
Biokhimiia; 1988 Jul; 53(7):1059-68. PubMed ID: 2846077
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of novel dihydropyridine, dihydropyrimidine, dithioacetal and chalcone derivatives from formylchromones.
Fawzy NM
Boll Chim Farm; 2004 Mar; 143(2):70-7. PubMed ID: 15191212
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and X-ray crystal structure of the calcium channel antagonist: dimethyl 1,4-dihydro-2,6-dimethyl-4-[4'-(4H-4-oxo-1-benzopyran-2-yl)phenyl]- 3,5-pyridine dicarboxylate.
Tunçbilek M; Ozbey S; Kendi E; Yildirim E; Erol K; Ertan R
Farmaco; 1999 Oct; 54(10):660-5. PubMed ID: 10575734
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, QSAR and calcium channel antagonist activity of new 1,4-dihydropyridine derivatives containing 1-methyl-4,5-dichloroimidazolyl substituents.
Hosseini M; Miri R; Amini M; Mirkhani H; Hemmateenejad B; Ghodsi S; Alipour E; Shafiee A
Arch Pharm (Weinheim); 2007 Oct; 340(10):549-56. PubMed ID: 17849444
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and calcium channel antagonist activity of dialkyl 1,4-dihydro-2,6-dimethyl-4-[3-(1-methoxy-carbonyl-4-substituted-1,4- dihydro-pyridyl)]-3,5-pyridinedicarboxylates.
Ramesh M; Matowe WC; Knaus EE; Wolowyk MW
Drug Des Discov; 1992 Jul; 8(4):313-23. PubMed ID: 1445996
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and calcium modulatory activity of 3-alkyloxy-carbonyl-4-(disubstituted)aryl-5-oxo-1,4,5,6,7,8-hexa-hydroquinoline derivatives.
Simşek R; Oztürk GS; Vural IM; Gündüz MG; Sarioglu Y; Safak C
Arch Pharm (Weinheim); 2008 Jan; 341(1):55-60. PubMed ID: 17994603
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of methyl 2-methyl-7,7-dihalo-5-phenyl-2-azabicyclo[4.1.0]hept-3-ene-4-carboxylates with calcium channel antagonist activity.
Mojarrad JS; Miri R; Knaus EE
Bioorg Med Chem; 2004 Jun; 12(12):3215-20. PubMed ID: 15158789
[TBL] [Abstract][Full Text] [Related]
10. Lipophilic 4-isoxazolyl-1,4-dihydropyridines: synthesis and structure-activity relationships.
Natale NR; Rogers ME; Staples R; Triggle DJ; Rutledge A
J Med Chem; 1999 Aug; 42(16):3087-93. PubMed ID: 10447952
[TBL] [Abstract][Full Text] [Related]
11. The new generation dihydropyridine type calcium blockers, bearing 4-phenyl oxypropanolamine, display alpha-/beta-adrenoceptor antagonist and long-acting antihypertensive activities.
Liang JC; Yeh JL; Wang CS; Liou SF; Tsai CH; Chen IJ
Bioorg Med Chem; 2002 Mar; 10(3):719-30. PubMed ID: 11814861
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of some 1,4-dihydropyridine derivatives and their calcium antagonistic activity.
Safak C; Sahin I; Sunal R
Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):119-22. PubMed ID: 2334450
[TBL] [Abstract][Full Text] [Related]
13. L-Type calcium channel blockers: from diltiazem to 1,2,4-oxadiazol-5-ones via thiazinooxadiazol-3-one derivatives.
Budriesi R; Cosimelli B; Ioan P; Ugenti MP; Carosati E; Frosini M; Fusi F; Spisani R; Saponara S; Cruciani G; Novellino E; Spinelli D; Chiarini A
J Med Chem; 2009 Apr; 52(8):2352-62. PubMed ID: 19323482
[TBL] [Abstract][Full Text] [Related]
14. [Synthesis of alkyl 2,6-dimethyl-(substituted or unsubstituted furyl)-1,4-dihydropyridine-3,5-dicarboxylates].
Zhang YH; Zhang ZQ; Wu Q
Yao Xue Xue Bao; 1991; 26(5):375-8. PubMed ID: 1957689
[TBL] [Abstract][Full Text] [Related]
15. [Solubilization and isolation of dihydropyridine calcium channel blocker receptor from the rabbit skeletal muscle].
Soldatov NM
Biokhimiia; 1988 Sep; 53(9):1418-26. PubMed ID: 2849480
[TBL] [Abstract][Full Text] [Related]
16. A chromone analog inhibits TNF-alpha induced expression of cell adhesion molecules on human endothelial cells via blocking NF-kappaB activation.
Kumar S; Singh BK; Pandey AK; Kumar A; Sharma SK; Raj HG; Prasad AK; Van der Eycken E; Parmar VS; Ghosh B
Bioorg Med Chem; 2007 Apr; 15(8):2952-62. PubMed ID: 17321745
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of some 1,4,5,6,7,8-hexahydroquinoline derivatives and their calcium antagonistic activity.
Safak C; Erdemli I; Sunal R
Arzneimittelforschung; 1993 Oct; 43(10):1052-5. PubMed ID: 8267668
[TBL] [Abstract][Full Text] [Related]
18. Syntheses, calcium channel agonist-antagonist modulation activities, and nitric oxide release studies of nitrooxyalkyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-(2,1,3-benzoxadiazol-4-yl)pyridine-5-carboxylate racemates, enantiomers, and diastereomers.
Shan R; Velazquez C; Knaus EE
J Med Chem; 2004 Jan; 47(1):254-61. PubMed ID: 14695839
[TBL] [Abstract][Full Text] [Related]
19. [Photoactivated radioactive analogs of calcium antagonists of 1,4-dihydropyridine series: synthesis and covalent labeling of the receptor in rabbit skeletal muscle].
Soldatov NM
Biokhimiia; 1988 Aug; 53(8):1247-55. PubMed ID: 2847815
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, evaluation of the calcium antagonistic activity and biotransformation of hexahydroquinoline and furoquinoline derivatives.
Simşek R; Safak C; Erol K; Ataman S; Ulgen M; Linden A
Arzneimittelforschung; 2003; 53(3):159-66. PubMed ID: 12705170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
